| RS2487083005 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2487083124 |
HGSNAT
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 73, Mucopolysaccharidosis |
| RS2487083724 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal dominant form |
| RS2487084077 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2487089011 |
HGSNAT
|
Health Risk |
Likely pathogenic |
— |
| RS2487089692 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2487089731 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal recessive form |
| RS2487090280 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal dominant form |
| RS2487090418 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal dominant form |
| RS2487096121 |
SLC20A2
|
Health Risk |
Pathogenic |
— |
| RS2487096513 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2487096929 |
SLC20A2
|
Health Risk |
Pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS2487096952 |
HGSNAT
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2487104940 |
PLAG1
|
Health Risk |
Likely pathogenic |
PLAG1-related disorder, PLAG1-related disorder |
| RS2487114607 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2487117774 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2487118434 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2487118957 |
HGSNAT
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 73, Mucopolysaccharidosis |
| RS2487119248 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 73, Mucopolysaccharidosis |
| RS2487125629 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 73, Mucopolysaccharidosis |
| RS2487138087 |
SLC39A14
|
Health Risk |
Likely pathogenic |
Hypermanganesemia with dystonia 2, Hypermanganesemia with dystonia 2 |
| RS2487140003 |
LIMK1
|
Health Risk |
Pathogenic |
Undetermined early-onset epileptic encephalopathy, Undetermined early-onset epileptic encephalopathy |
| RS2487143337 |
TTPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS2487147387 |
TTPA
|
Health Risk |
Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS2487147481 |
TTPA
|
Health Risk |
Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS2487147566 |
TTPA
|
Health Risk |
Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS2487147613 |
TTPA
|
Health Risk |
Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS2487147705 |
TTPA
|
Health Risk |
Pathogenic |
— |
| RS2487147925 |
TTPA
|
Health Risk |
Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS2487147948 |
TTPA
|
Health Risk |
Pathogenic |
— |
| RS2487147973 |
TTPA
|
Health Risk |
Pathogenic |
— |
| RS2487153916 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2487154014 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2487154105 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2487160901 |
ANK1
|
Health Risk |
Likely pathogenic |
— |
| RS2487161140 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487161296 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487161354 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2487161455 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487161473 |
ANK1
|
Health Risk |
Likely pathogenic |
— |
| RS2487164970 |
TTPA
|
Health Risk |
Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS2487165321 |
TTPA
|
Health Risk |
Pathogenic |
— |
| RS2487165508 |
TTPA
|
Health Risk |
Pathogenic |
— |
| RS2487165803 |
TTPA
|
Health Risk |
Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS2487165831 |
TTPA
|
Health Risk |
Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS2487165874 |
TTPA
|
Health Risk |
Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS2487176728 |
SLC20A2
|
Health Risk |
Pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS2487183134 |
SLC20A2
|
Health Risk |
Pathogenic |
— |
| RS2487190152 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2487190488 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2487191388 |
SLC20A2
|
Health Risk |
Pathogenic |
— |
| RS2487191561 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2487191620 |
SLC20A2
|
Health Risk |
Pathogenic |
— |
| RS2487191870 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2487191885 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2487192220 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2487199918 |
TTPA
|
Health Risk |
Likely pathogenic |
— |
| RS2487199926 |
TTPA
|
Health Risk |
Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS2487200395 |
TTPA
|
Health Risk |
Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS2487200887 |
TTPA
|
Health Risk |
Pathogenic |
— |
| RS2487201123 |
TTPA
|
Health Risk |
Pathogenic |
— |
| RS2487201178 |
TTPA
|
Health Risk |
Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS2487201275 |
TTPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS2487201425 |
TTPA
|
Health Risk |
Pathogenic |
— |
| RS2487206621 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2487230219 |
SLC20A2
|
Health Risk |
Pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS2487257832 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487261863 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487262838 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487263004 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487263636 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS2487264136 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487264288 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487266223 |
WRN
|
Health Risk |
Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS2487266366 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487267049 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487268115 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS2487269253 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS2487270254 |
WRN
|
Health Risk |
Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS2487273021 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487274727 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487275013 |
CHD7
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2487278624 |
ERLIN2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 18, Hereditary spastic paraplegia 18 |
| RS2487279652 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487281631 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487283883 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487284308 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487285284 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487285824 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487289295 |
ERLIN2
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2487294702 |
ERLIN2
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2487296166 |
SLC20A2
|
Health Risk |
Pathogenic |
— |
| RS2487297016 |
SLC20A2
|
Health Risk |
Pathogenic |
— |
| RS2487299097 |
SLC20A2
|
Health Risk |
Pathogenic |
— |
| RS2487305222 |
ERLIN2
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2487305557 |
ERLIN2
|
Health Risk |
Pathogenic |
Spastic paraplegia 18a, autosomal dominant |
| RS2487326803 |
ERLIN2
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2487332031 |
ERLIN2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 18, Hereditary spastic paraplegia 18 |
| RS2487359201 |
PLPBP
|
Health Risk |
Pathogenic |
— |
| RS2487359546 |
PLPBP
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |